Literature DB >> 1378679

Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids.

A Banning1, P Sjøgren, F Kaiser.   

Abstract

Continuous Reaction Time (CRT) was measured in cancer patients receiving peripherally acting analgesics either alone (n = 16) or in combination with opioids (n = 16). Comparison was performed matching the patients from each group for age and performance status. Statistically significant prolongations of CRT and higher sedation scores were seen in the opioid group, while performance status did not have any influence on CRT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378679     DOI: 10.1111/j.1399-6576.1992.tb03501.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

Review 1.  The cognitive effects of opioids in cancer: a systematic review.

Authors:  Geana Paula Kurita; Lena Lundorff; Cibele Andrucioli de Mattos Pimenta; Per Sjøgren
Journal:  Support Care Cancer       Date:  2008-09-02       Impact factor: 3.603

2.  Integrating pain management in clinical practice.

Authors:  Robert N Jamison; Robert R Edwards
Journal:  J Clin Psychol Med Settings       Date:  2012-03

3.  Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment.

Authors:  James Prosser; Lisa J Cohen; Matthew Steinfeld; Daniel Eisenberg; Edythe D London; Igor I Galynker
Journal:  Drug Alcohol Depend       Date:  2006-03-20       Impact factor: 4.492

4.  [Differentiation of pain-related and morphine related impairment of cognitive performance and mood in bone marrow transplantation patients].

Authors:  J Lorenz; U Baumgärtner; A R Zander; B Bromm
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

Review 5.  Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.

Authors:  Gustavo A Angarita; Nazli Emadi; Sarah Hodges; Peter T Morgan
Journal:  Addict Sci Clin Pract       Date:  2016-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.